352 material Form 8-K filings that 310 companies we cover made with the SEC in August 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
DXP Enterprises reported second quarter 2024 results on August 8, 2024. Sales rose 4.1% year over year to $445.6 million, but diluted EPS fell to $1.00 from $1.06 and net income declined to $16.7 million from $19.1 million. Adjusted EBITDA rose to $48.2 million from $45.3 million, and the company said it expects to close at least two more acquisitions in the second half of 2024.
Sales of $445.6 million, up 4.1% from $428.0 million a year earlier and up 8.0% from $412.6 million in the first quarter of 2024
Diluted EPS of $1.00 versus $1.06 a year earlier; adjusted diluted EPS of $1.02 versus $1.06
Adjusted EBITDA of $48.2 million, up from $45.3 million, with a 10.8% margin versus 10.6%
Free cash flow of $30.0 million for the six months ended June 30, 2024; four acquisitions completed through the second quarter
Victory Capital reported second-quarter 2024 revenue of $219.6 million, up 7.5% from a year earlier, and GAAP net income of $74.3 million, up 31.0%. The company also raised its quarterly dividend 11% to $0.41 per share, but total AUM fell to $168.7 billion on net outflows of $1.7 billion during the quarter.
Q2 2024 GAAP diluted EPS was $1.12, compared with $0.83 in Q2 2023; adjusted net income with tax benefit per diluted share was $1.31, compared with $1.11.
Revenue was $219.6 million, up 7.5% from $204.2 million, driven by higher average AUM.
Total AUM was $168.7 billion at June 30, 2024, down from $170.3 billion at March 31, 2024, on net outflows of $1.7 billion.
Quarterly dividend increased to $0.41 per share from $0.37, payable September 25, 2024 to holders of record on September 10, 2024.
DXC Technology reported first-quarter fiscal 2025 results for the quarter ended June 30, 2024, with total revenue down 6% year-over-year to $3.24 billion and GAAP diluted EPS down 18% to $0.14. The company raised parts of its full-year fiscal 2025 outlook, including non-GAAP diluted EPS and free cash flow, which may matter to shareholders even as reported revenue and GAAP earnings declined.
Net income was $25 million, down 40% year-over-year; non-GAAP diluted EPS was $0.74, up 17%.
Operating cash flow was $238 million, up 87%; free cash flow was $45 million.
Full-year non-GAAP diluted EPS outlook is now $2.75 to $3.00, up from $2.50 to $3.00 at the low end.
Full-year free cash flow outlook was raised to approximately $450 million from approximately $400 million.
Take-Two reported fiscal first-quarter 2025 results for the period ended June 30, 2024. Net Bookings rose 1% to $1.22 billion and GAAP net revenue rose 4% to $1.34 billion, but the GAAP net loss widened to $262.0 million, or $1.52 per share, from $206.0 million, or $1.22 per share, a year earlier. The company reiterated its fiscal 2025 Net Bookings outlook of $5.55 to $5.65 billion and revised its GAAP outlook, which now projects a net loss of $(757) to $(690) million.
Net Bookings were $1.22 billion, up 1% from $1.20 billion a year earlier; the company said this was in line with guidance
GAAP net revenue rose 4% to $1.34 billion from $1.28 billion
GAAP net loss was $262.0 million, or $1.52 per share, versus $206.0 million, or $1.22 per share; business reorganization costs were $49.5 million
Fiscal 2025 Net Bookings outlook reiterated at $5.55 to $5.65 billion; GAAP net loss outlook is $(757) to $(690) million
Douglas Emmett reported second quarter 2024 results on August 8, 2024. Revenue fell 3.0% to $245.8 million and FFO fell 4.5% to $92.1 million, or $0.46 per fully diluted share, while net income attributable to common stockholders rose to $10.9 million, or $0.06 per diluted share, mainly because the prior-year period included accelerated depreciation tied to removing Barrington Plaza from the rental market. The company narrowed its 2024 guidance to $0.05 to $0.09 per diluted share for net income and $1.65 to $1.69 per fully diluted share for FFO.
Total revenues were $245.8 million, down from $253.4 million in the second quarter of 2023, as vacancy at Barrington Plaza and lower office occupancy offset higher parking and residential revenue.
Net income attributable to common stockholders was $10.9 million, compared with a loss of $7.3 million a year earlier.
FFO was $92.1 million, or $0.46 per fully diluted share, down from $96.4 million, or $0.48, a year earlier, due to higher interest expense and lower revenues.
2024 guidance was narrowed to $0.05 to $0.09 per diluted share for net income and $1.65 to $1.69 per fully diluted share for FFO; the filing does not state the prior range.
PDF Solutions reported second-quarter 2024 results on August 8, 2024. Revenue of $41.7 million was flat year over year, while GAAP net income fell to $1.7 million, or $0.04 per diluted share, from $6.8 million, or $0.17, a year earlier. The company reiterated its expectation for 20% revenue growth in the second half of 2024 and said the results are preliminary until it files its Form 10-Q.
Total revenue of $41.7 million compared with $41.6 million in Q2 2023; analytics revenue rose 3% to $38.1 million.
GAAP net income of $1.7 million, or $0.04 per diluted share, versus $6.8 million, or $0.17, in Q2 2023.
Non-GAAP diluted EPS of $0.18, compared with $0.19 in Q2 2023.
CEO John Kibarian reiterated the expectation that second-half 2024 revenue will grow 20% over the prior-year period.
Life360 reported unaudited Q2 2024 revenue of $84.9 million, up 20% year over year, and a net loss of $(11.0) million, compared with $(4.4) million a year earlier. The loss includes $5.8 million in IPO-related transaction costs. The company raised its full-year 2024 revenue and Adjusted EBITDA guidance, which matters to shareholders because it signals higher expected revenue and profit, though GAAP results were weaker than the prior year.
Q2 2024 total revenue was $84.9 million, up 20% year over year; net loss was $(11.0) million versus $(4.4) million in Q2 2023, including $5.8 million in IPO-related transaction costs.
Adjusted EBITDA was $11.0 million in Q2 2024, compared with $5.7 million in Q2 2023.
2024 consolidated revenue guidance was raised to $370 million-$378 million from $365 million-$370 million; Adjusted EBITDA guidance was raised to $36 million-$41 million from $30 million-$35 million.
Global monthly active users reached approximately 70.6 million, up 31% year over year, and Paying Circles reached 2.0 million.
Arcus Biosciences reported second-quarter 2024 revenue of $39 million, up from $29 million a year earlier, while its net loss widened to $93 million from $75 million as research and development expenses rose to $115 million from $84 million. Cash, cash equivalents and marketable securities totaled $1.0 billion at June 30, 2024, and the company said that balance will fund operations into 2027.
Q2 2024 revenue was $39 million versus $29 million in Q2 2023; six-month revenue was $184 million versus $54 million.
Q2 net loss was $93 million versus $75 million; net loss per share was $1.02 versus $1.04.
R&D expenses were $115 million versus $84 million, driven by higher clinical trial and headcount-related costs for late-stage programs.
Cash and marketable securities were $1.0 billion at June 30, 2024, including $320 million received from Gilead for its January 2024 equity investment.
e.l.f. Beauty reported results for the three months ended June 30, 2024, with net sales up 50% to $324.5 million, but GAAP net income fell to $47.6 million from $53.0 million and GAAP diluted earnings per share fell to $0.81 from $0.93. The company raised its fiscal 2025 net sales and adjusted EPS outlook, which may matter to shareholders because the higher sales forecast is offset by lower GAAP profit in the quarter.
Net sales rose 50% to $324.5 million; adjusted diluted EPS was $1.10, unchanged from the prior-year quarter.
GAAP diluted EPS was $0.81 versus $0.93; SG&A rose to $180.6 million, or 56% of net sales.
Cash and cash equivalents were $109.0 million at June 30, 2024; long-term debt and finance lease obligations were $159.2 million.
Century Aluminum reported second quarter 2024 net sales of $560.8 million, up $71.3 million from the first quarter, and adjusted EBITDA attributable to Century stockholders of $34.2 million, up $9.2 million. The company posted a net loss of $2.5 million, compared with net income of $246.8 million in the first quarter, which included a $245.9 million bargain purchase gain from the Jamalco acquisition. The company expects third quarter adjusted EBITDA of $65 million to $75 million.
Q2 2024 net sales $560.8 million vs. $489.5 million in Q1 2024
Net loss attributable to Century stockholders of $2.5 million, or $0.03 per diluted share, vs. net income of $246.8 million in Q1, which included a $245.9 million bargain purchase gain
Adjusted EBITDA attributable to Century stockholders $34.2 million vs. $25.0 million in Q1 2024
Third quarter 2024 adjusted EBITDA outlook of $65 million to $75 million
StepStone Group reported results for the quarter ended June 30, 2024, its first quarter of fiscal 2025. Total revenues rose 5% to $186.4 million, but net income fell 3% to $48.0 million and GAAP diluted earnings per share fell 41% to $0.20, with performance fees down 79%. The company also declared a quarterly dividend of $0.24 per share, payable September 13, 2024.
Total revenues were $186.4 million, up 5% from $178.0 million a year earlier; management and advisory fees, net rose 29% to $178.0 million.
GAAP net income attributable to StepStone was $13.3 million, versus $21.3 million a year earlier; diluted EPS was $0.20 versus $0.34.
Non-GAAP adjusted net income rose 95% to $57.2 million, and fee-related earnings rose 61% to $71.7 million, with a 40% FRE margin.
Assets under management were $169.3 billion, up 19%; the quarterly dividend is payable September 13, 2024 to holders of record on August 30, 2024.
CarGurus reported second quarter 2024 results with total revenue of $218.7 million, down 9% from a year earlier, and a GAAP net loss of $68.7 million, compared with net income of $13.8 million in the same period of 2023. Marketplace revenue rose 14% to $195.2 million, while the net loss reflects a $127.7 million goodwill and long-lived asset impairment. The company also gave third quarter 2024 guidance for total revenue of $212 million to $232 million.
Q2 2024 total revenue was $218.7 million, down 9% year over year; Marketplace revenue rose 14% to $195.2 million.
GAAP net loss was $68.7 million, or $0.66 per diluted share, versus net income of $13.8 million in Q2 2023; the loss includes $127.7 million in impairment charges.
Non-GAAP Consolidated Adjusted EBITDA was $55.6 million, up 23% year over year, with a 25% margin.
Third quarter 2024 guidance: total revenue of $212 million to $232 million, Non-GAAP EPS of $0.38 to $0.44.
Arlo Technologies reported second-quarter 2024 revenue of $127.4 million, up 10.8% year over year, with service revenue of $60.3 million up 19.7%. GAAP net loss was $11.6 million, or $(0.12) per share, versus $(0.08) a year earlier, while non-GAAP net income per share rose to $0.10 from $0.06. The company guided third-quarter revenue to $132 million to $142 million and GAAP net loss per share to $(0.07) to $(0.01).
Q2 2024 revenue $127.4 million, up 10.8% year over year; service revenue $60.3 million, up 19.7%
GAAP net loss per share $(0.12) in Q2 2024 versus $(0.08) in Q2 2023; non-GAAP net income per share $0.10 versus $0.06
Q3 2024 outlook: revenue $132 million to $142 million; GAAP net loss per share $(0.07) to $(0.01); non-GAAP $0.08 to $0.14
Ended Q2 with $144.0 million in cash and short-term investments and annual recurring revenue of $235.0 million, up 21.4%
Expedia Group reported second quarter 2024 revenue of $3.6 billion, up 6% from a year earlier, and diluted EPS of $2.80 versus $2.54. CEO Ariane Gorin said July brought a more challenging macro environment and softer travel demand, and the company is adjusting its expectations for the rest of the year.
Q2 2024 gross bookings were $28.8 billion, up 6%, and revenue was $3.6 billion, up 6%.
Diluted EPS was $2.80 versus $2.54; adjusted EPS was $3.51 versus $2.89, up 21%.
Net income attributable to Expedia Group was $386 million, roughly flat with $385 million a year earlier.
Management said it has seen a softening in travel demand in July and is adjusting expectations for the rest of 2024.
Tennant Company reported second-quarter 2024 net sales of $331.0 million, up 2.9% from a year earlier, while net income fell 10.9% to $27.9 million and diluted EPS fell to $1.45 from $1.68. The company raised its full-year 2024 guidance, with net sales now expected at $1,280 million to $1,305 million and Adjusted EBITDA at $205 million to $215 million.
Q2 2024 net sales were $331.0 million, up 2.9%, or 2.7% organic; Asia Pacific sales fell 13.5%.
Net income was $27.9 million versus $31.3 million, and diluted EPS was $1.45 versus $1.68; the company cited ERP modernization and transaction and integration costs.
Adjusted diluted EPS was $1.83 versus $1.86 a year earlier, and Adjusted EBITDA was $58.6 million, up 1.7%.
Updated 2024 guidance: net sales $1,280 million to $1,305 million (previously $1,270 million to $1,295 million); Adjusted EBITDA $205 million to $215 million (previously $198 million to $213 million).
XPEL reported second-quarter 2024 results on August 8, 2024, with revenue up 7.5% to $109.9 million, which the company called a record. Net income fell 4.5% to $15.0 million, or $0.54 per share, from $15.7 million, or $0.57 per share, a year earlier, and the company kept its 2024 annual revenue growth projection at 8-10%. Revenue growth was offset by higher operating expenses, and the results are preliminary and unaudited until the Form 10-Q, expected on or before August 9, 2024.
Q2 2024 revenue of $109.9 million, up 7.5% from $102.2 million in Q2 2023
Net income of $15.0 million, or $0.54 per diluted share, versus $15.7 million, or $0.57, a year earlier
EBITDA of $21.8 million, or 19.9% of revenue, versus $22.4 million, or 21.9%, in Q2 2023
China revenue fell 45.7% to $4.4 million; 2024 annual revenue growth projection remains 8-10%
Liquidity Services reported fiscal third-quarter 2024 results for the quarter ended June 30, 2024, with GMV of $380.4 million (up 14%) and revenue of $93.6 million (up 16%). GAAP net income fell to $6.0 million, or $0.19 per diluted share, from $6.5 million, or $0.21, a year earlier, as sales, marketing, technology and operations spending rose and $1.1 million of acquisition-related and litigation settlement costs were incurred. The company also issued fourth-quarter fiscal 2024 guidance for GMV of $330 million to $365 million and GAAP net income of $5.0 million to $7.0 million.
Q3 FY24 GMV was $380.4 million, up 14%, and revenue was $93.6 million, up 16%, versus the prior-year quarter.
GAAP net income was $6.0 million ($0.19 per diluted share), down from $6.5 million ($0.21) a year earlier; non-GAAP adjusted EBITDA rose to $14.7 million from $13.3 million.
Q4 FY24 guidance: GMV of $330 million to $365 million, GAAP net income of $5.0 million to $7.0 million, and GAAP diluted EPS of $0.16 to $0.22.
As of June 30, 2024, the company reported cash balances of $136.8 million and no financial debt, with $7.6 million remaining under its share repurchase authorization.
Advanced Drainage Systems reported fiscal first-quarter 2025 results for the period ended June 30, 2024, with net sales up 4.8% to $815.3 million but net income down 6.7% to $162.3 million. The company confirmed its fiscal 2025 targets and declared a quarterly dividend of $0.16 per share, a 14% increase over the prior year amount. Higher sales alongside lower profit leave the quarter's direction mixed for shareholders.
Net sales rose 4.8% to $815.3 million; net income fell 6.7% to $162.3 million
Diluted EPS was $2.06 versus $2.18 a year earlier, down 5.5%; adjusted EPS was flat at $2.06
Adjusted EBITDA was $275.5 million, with a margin of 33.8% versus 36.2% a year earlier
Fiscal 2025 targets confirmed: net sales $2.925 billion to $3.025 billion; Adjusted EBITDA $940 million to $980 million; quarterly dividend $0.16 per share payable September 13, 2024
Sally Beauty Holdings reported third-quarter fiscal 2024 net sales of $942.3 million, up 1.2%, with comparable sales up 1.5%. GAAP diluted earnings per share fell 21.7% to $0.36 from $0.46 a year earlier, as operating earnings declined to $71.8 million from $90.1 million. The company maintained its full-year fiscal 2024 guidance.
Q3 net sales were $942.3 million, up 1.2%; comparable sales rose 1.5%.
GAAP diluted EPS was $0.36 versus $0.46 a year earlier; adjusted diluted EPS was $0.45 versus $0.49.
GAAP operating earnings were $71.8 million, with a 7.6% operating margin, versus $90.1 million and 9.7% a year earlier.
Full-year fiscal 2024 guidance was maintained, including net sales and comparable sales approximately flat and operating cash flow of approximately $240 million.
Privia Health reported second-quarter 2024 results on August 8, 2024, with total revenue of $422.3 million, up 2.2% from a year earlier, while net income attributable to the company fell to $3.5 million from $7.3 million and diluted EPS fell to $0.03 from $0.06. The company also raised its full-year 2024 guidance to the mid-to-high end of its ranges for all metrics, including GAAP revenue of $1,600 million to $1,675 million, so shareholders get higher revenue expectations alongside lower GAAP earnings this quarter.
Q2 2024 total revenue $422.3 million, up 2.2% from $413.4 million; operating income $5.1 million, down 27.0%
Net income attributable to Privia Health $3.5 million, or $0.03 per share, versus $7.3 million, or $0.06, a year earlier
Adjusted EBITDA $22.0 million, up 14.0%; cash and cash equivalents $387.4 million and no debt as of the quarter
FY 2024 guidance raised to mid-to-high end; GAAP revenue guidance $1,600 million to $1,675 million, Adjusted EBITDA $85 million to $90 million
Haemonetics reported first quarter fiscal 2025 results for the period ended June 29, 2024, with revenue up 8.0% to $336.2 million, while GAAP earnings per diluted share fell to $0.74 from $0.80 and adjusted earnings per diluted share fell 2.9% to $1.02. The company reaffirmed its fiscal 2025 revenue, adjusted operating margin, adjusted earnings per share and free cash flow guidance, so shareholders see stronger sales but lower profit in the quarter with no change to the full-year outlook.
Revenue was $336.2 million, up 8.0% from the prior year; organic revenue grew 2.8%, with Hospital up 30.7% and Plasma down 2.7%.
GAAP operating income was $39.8 million, an 11.8% margin, versus $53.7 million and a 17.2% margin a year earlier.
Operating cash outflow was $27.4 million and free cash outflow was $16.9 million, compared with operating cash inflow of $19.1 million a year earlier.
Fiscal 2025 adjusted earnings per diluted share guidance of $4.45 to $4.75 was reaffirmed.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.